between the patient groups were demonstrated. The results may influence the surgical management of these patients. Discussion PROF . V. WRIGHT (Leeds) I am interested to know how you determine when the wound is healed.
DR. MOWAT (Rhoads and Kasinskas, 1942 DR. MOWAT With respect, sir, these are impressions that people have. They are largely undocumented impressions and we set out to investigate them. Our results suggest the very opposite ofwhat many people think; haemoglobin values had nothing to do with wound healing and serum proteins seemed likely to produce little difference. We looked at the erythrocyte sedimentation rate and the activity of the disease and found no correlation. DR. A. J. POPERT I was going to point out that yours is not the only paper which has been written on this subject. Peter Davis and I published a paper on this in 1958 (Popert and Davis, 1958) and I presented a paper on some eight cases to the Heberden Society in 1963 (Popert, 1963) . There is a vast mass of other data (cited by Popert, 1962) on this subject, which you may not have fully culled. Evidence has been accumulating which suggests that polymyositis may be due to a breakdown of tolerance to skeletal muscle. If this is so, lymphocytes should be sensitive to muscle and express this sensitivity by undergoing transformation in the presence of muscle in vitro. This hypothesis has been tested using a quantitative method of estimating blast transformation.
Peripheral blood lymphocytes were separated from venous blood, suspended in tissue culture fluid, and incubated with varying concentrations of an homogenate of normal human muscle. Tritiated thymidine was added before taking the cultures down on the fifth day. The DNA was extracted and sampled in a liquid scintillation counter for the amount of incorporated tritium present. The amount of tritium incorporated by lymphocytes in the presence of muscle was compared with that incorporated in lymphocytes grown alone, the differences between these figures giving a measure of stimulation or inhibition produced by the muscle antigen. The results are seen in the accompanying Table. Lymphocytes from patients with polymyositis and polymyalgia rheumatica showed stimulation by muscle, whereas those from normal healthy controls and patients with unrelated disease showed inhibition or insignificant stimulation. A lesser, but nevertheless significant, degree of stimulation was seen in patients with muscle wasting and rheumatoid arthritis. In patients with polymyositis and polymyalgia rheumatica the magnitude of the response was directly related to the degree of activity of the disease at the time of testing. Tests for rheumatoid factor sharply separate patients with classical rheumatoid arthritis from those suffering from conditions such as ankylosing spondylitis and psoriatic arthritis. One possible explanation might be that these two populations differ in their potential humoral antibody response pattern. This was investigated by challenging 98 subjects (none of whom had suffered from typhoid or been injected with 'TAB') with a single, intradermal injection of 0-1 ml. monovalent typhoid vaccine. Blood samples taken immediately before, and 7 and 14 days after, injection were tested for typhoid agglutinins using the 'microtitre' technique. Total and 2-mercaptoethanol-resistant (MER) titres were determined. The method proved highly sensitive and the 'O' antigen titres were used for analysis as these were clearer and more reproducible than the 'H' titres. There was reasonably good correlation with the standard Vidal test. Appropriate experiments established that the presence of rheumatoid factor did not modify the 'O' titres, and that the MER titres reflected IgG activity. The opportunity was taken also to study the influence ofcertain drugs on this primary antibody response. The conclusions were: (1) Patients with seropositive rheumatoid arthritis produced antibody responses indistinguishable from controls. (2) Patients withankylosingspondylitis, psoriaticarthritis, and colitic arthritis produced responses (both total and MER) at least as great as those seen in seropositive rheumatoid arthritis. (3) Mean antibody responses in patients receiving azathioprine and/or prednisolone showed no evidence of suppression. (4) Unexpectedly, antibody responses (both total and MER) in patients receiving gold injections were significantly lower than in other rheumatoid subjects (P < 0-01). DR. P. J. L. HOLT (London) The response to gold was interesting. Does it correspond to the clinical response? I ask this because gold is known to attach to immunoglobulins, particularly when complexed, and a low immunoglobulin response might thus be specific or nonspecific (Lorber, Bovy, and Chang, 1972) . We have now found that, of the non-steroidal anti-inflammatory agents so far tried, gold is the only one that suppresses complement conversion when it is accompanied by clinical improvement. It is quite dramatic in doing this and, of course, the rheumatoid factor titre also tends to fall (Versey and Holt, unpublished Soothill and Steward (1971) , in experimental work on mice who developed lupus-like nephritis, suggested that the affinity of the antibodies is at fault rather than the total quantity. Have you had a chance to look at that ? DR. CURREY No, we have done this only very crudely up to now. DR. M. K. JASANI (Horsham) I should like to draw the attention of the Society to a possible relationship between your findings and those described by Dr. Esiri and her colleagues in the previous paper. Since, in experimental studies, steroids have been found to suppress more effectively the induction of a primary immunological response than either the established state, that is antibody production, or the secondary immunological response, I wonder whether the abnormality of lymphocyte function in polymyositis might not be incidental, whereas in RA it might not only be central but well established. Maybe some such explanation could help account for the observed fact that in polymyositis a good clinical response can be obtained readily using a high dose of prednisolone and maintained thereafter with a low dose, whereas in RA it is not uncommon to encounter difficulty in maintaining a good response even using a high dose of the steroid. DR. CURREY Another way of looking at it is that polymyositis is a self-limiting disease and hence ideally treated with steroids, whereas rheumatoid arthritis is not. DR. JASANI Although I agree that polymyositis is selflimiting, I wonder whether this is because in polymyositis 
